AllianceBernstein L.P. ("AB") and AllianceBernstein Holding L.P. ("AB Holding") (NYSE: AB) today reported financial and operating results ...
Open a VIP account (an enterprise account with priority handling, 24/7 dedicated customer care, unlimited usage/users, help ...
Presentation will introduce ART26.12, the first selective FABP5 inhibitor to enter human clinical studies, to the world’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results